3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
6
Carcinoid Tumor
5
Neoplasms
4
Carcinoma
3
Vipoma
2
Neoplasm Metastasis
2
Intestinal Obstruction
2
Carcinoma, Islet Cell
2
Somatostatinoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Malignant Carcinoid Syndrome
1
Lymphangiomyoma
1
Lymphangioleiomyomatosis
1
Insulinoma
1
Glucagonoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gastrinoma
1
Diarrhea
1
Chylous Ascites
1
Chylothorax
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Ascites
1
Adenoma, Islet Cell
1
Interventions
Paclitaxel
57
Carboplatin
51
Bevacizumab
41
Taxes
28
liposomal doxorubicin
21
Gemcitabine
19
Immunoglobulin G
17
Disulfides
17
pembrolizumab
15
Topotecan
12
rucaparib
10
Cyclophosphamide
9
Cisplatin
9
Docetaxel
8
olaparib
7
Doxorubicin
7
pazopanib
6
mirvetuximab soravtansine
6
cediranib
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
sargramostim
4
niraparib
4
Surgical Procedures, Operative
4
Drug Therapy
4
Cytoreduction Surgical Procedures
4
Albumin-Bound Paclitaxel
4
veliparib
3
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Fallopian Tube Neoplasms
×
Octreotide
×
Clear all
No trials found.